Answers are grounded in this paper and cite their sources.
A 70-year-old male patient received ticagrelor 90 mg twice daily and aspirin 100 mg once daily as dual antiplatelet therapy after operation for coronary stent implanting. On day 2 of treatment, he developed traces of blood in sputum. The hemoptysis became worse and times became more after that. On day 42, the patient developed massive hemoptysis about 100 ml. Ticagrelor was discontinued by himself. The patient then was given oxygen inhalation, expectorant drug and hemostatic agents. Anticoagulant therapy was adjusted for the combined use of clopidogrel 75 mg once daily and aspirin 100 mg once daily. On day 4 of the ticagrelor withdrawal, the amount of hemoptysis was obviously reduced. On day 7, the hemoptysis ceased.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: